Estradiol
Oral estradiol has product-specific menopause and other hormone indications.
FDA-approved product context
Oral estradiol has product-specific menopause and other hormone indications.
Reviewed October 10, 2026. Product and route distinctions stay attached to the source; this is not a treatment recommendation.
Evidence and source limits
The retrieved oral estradiol tablet label lists moderate-to-severe menopausal vasomotor and vulvovaginal symptoms, specified hypoestrogenism uses and other narrow indications. It notes topical vaginal products should be considered when treatment is solely for vaginal symptoms.
Estrogen products differ by route and indication. Cancer and thromboembolic contraindications and endometrial risks need product-specific review. The February 2026 labeling changes for selected products do not establish that every estradiol label is identical.
Approval applies to the specific labeled product, route and indication, not every preparation of this ingredient or a wellness mixture. Read the original full label and discuss individual circumstances with a medical professional. No dosing or preparation instructions are included.
Interpretation is limited to the source linked above. Educational source review, not independent medical review. No dosing, preparation instructions, seller links or treatment endorsement.